Skip to main content

Peer Review reports

From: Prognostic factors and clinical efficacy of second-line treatments of Pneumocystis jirovecii pneumonia for non-HIV patients after first-line treatment failure

Original Submission
1 Mar 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
30 Mar 2022 Reviewed Reviewer Report
5 Apr 2022 Reviewed Reviewer Report
20 Apr 2022 Author responded Author comments - Jing Yang
Resubmission - Version 3
20 Apr 2022 Submitted Manuscript version 3
22 Apr 2022 Author responded Author comments - Jing Yang
Resubmission - Version 4
22 Apr 2022 Submitted Manuscript version 4
29 Apr 2022 Reviewed Reviewer Report
1 May 2022 Reviewed Reviewer Report
13 May 2022 Author responded Author comments - Jing Yang
Resubmission - Version 5
13 May 2022 Submitted Manuscript version 5
18 May 2022 Reviewed Reviewer Report
27 May 2022 Author responded Author comments - Jing Yang
Resubmission - Version 6
27 May 2022 Submitted Manuscript version 6
Publishing
6 Jun 2022 Editorially accepted
14 Jun 2022 Article published 10.1186/s12879-022-07523-y

You can find further information about peer review here.

Back to article page